Recent News

• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.29.2025 - Prime Medicine to Participate in Upcoming Investor Conferences
• 05.29.2025 - Prime Medicine to Participate in Upcoming Investor Conferences
• 05.19.2025 - Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
• 05.19.2025 - Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
• 05.19.2025 - Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
• 05.19.2025 - Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

Recent Filings

• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 8-K Current report
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.19.2025 - EX-99.1 EX-99.1
• 05.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.12.2025 - 4 Statement of changes in beneficial ownership of securities